Evidence map›Paper›PMID 22118463›Full record

ArticleCell2011

Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms.

Elena Piskounova, Christos Polytarchou, James E Thornton, Robert J LaPierre, Charalabos Pothoulakis, John P Hagan, Dimitrios Iliopoulos, Richard I Gregory

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 397 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
397citing papers in PubMed, 1 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

397 citing papers in PubMed, 1 synthesis or guideline pooled it, 610 citations in OpenAlex.

  1. miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Genetic insights into the relationship between age at menarche and mental health-related phenotypes.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Article
  6. Article
  7. Review
  8. PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

337 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Elena PiskounovaStem Cell Program, Children's Hospital, Boston, MA 02115, USA.
Christos Polytarchou
James E Thornton
Robert J LaPierre
Charalabos Pothoulakis
John P Hagan
Dimitrios Iliopoulos
Richard I Gregory
Boston Children's Hospital · USHarvard University · USUniversity of California, Los Angeles · US

Funding

Regulation of microRNA Biogenesis in Stem CellsR01GM086386 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI GREGORY, RICHARD I. · 2009 to 2018
$3.1M
NIGMS NIH HHS 1R01GM086386-01A1NIGMS NIH HHS R01 GM086386
6 · The paper itself

Abstract

Lin28A and Lin28B selectively block the expression of let-7 microRNAs and function as oncogenes in a variety of human cancers. Lin28A recruits a TUTase (Zcchc11/TUT4) to let-7 precursors to block processing by Dicer in the cell cytoplasm. Here we find that unlike Lin28A, Lin28B represses let-7 processing through a Zcchc11-independent mechanism. Lin28B functions in the nucleus by sequestering primary let-7 transcripts and inhibiting their processing by the Microprocessor. The inhibitory effects of Zcchc11 depletion on the tumorigenic capacity and metastatic potential of human cancer cells and xenografts are restricted to Lin28A-expressing tumors. Furthermore, the majority of human colon and breast tumors analyzed exclusively express either Lin28A or Lin28B. Lin28A is expressed in HER2-overexpressing breast tumors, whereas Lin28B expression characterizes triple-negative breast tumors. Overall our results illuminate the distinct mechanisms by which Lin28A and Lin28B function and have implications for the development of new strategies for cancer therapy.

Indexed as

Gene Expression Regulation, NeoplasticAmino Acid SequenceBreast NeoplasmsCell NucleolusCell NucleusColonic NeoplasmsDNA-Binding ProteinsFemaleHumansMicroRNAsMolecular Sequence DataNeoplasm InvasivenessRNA-Binding ProteinsTranscription, GeneticDNA-Binding ProteinsLin28A protein, humanLIN28B protein, humanMicroRNAsmirnlet7 microRNA, humanRNA-Binding ProteinsTUT4 protein, human

Identifiers

PMID22118463
PMCPMC3227872
OpenAlexW2034806022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.